News
Researchers identify genetic variants that modulate how water purification byproducts influence the risk of colorectal cancer
A study led by IDIBELL and ICO identifies genetic variants that could modulate the body’s response to trihalomethanes and influence the risk of developing colorectal cancer.
Researchers from IDIBELL, Bellvitge Hospital and the UB promote a paradigm shift in the treatment of bacteriemia by Staphylococcus aureus
The combination of antibiotics reduces mortality in patients with high-risk Staphylococcus aureus bacteriemia by half, if applied in a personalized way.
Bellvitge launches the first research program on adult rare diseases in Spain with an interprofessional approach with precision medicine
REMMA Bellvitge: the new research program that brings together professionals from the Bellvitge Health Campus who work on adult rare diseases
The AECC allocates more than 900,000 euros to oncological research at IDIBELL
AECC will fund innovative strategies to improve the treatment of childhood cancer and overcome resistance in prostate cancer
The AES grants, more resources to investigate: IDIBELL receives about 4.5 million euros for 19 new health projects
The Acción Estratégica en Salud (AES) of the Carlos III Health Institute (ISCIII) reaffirms, once again, as the main engine for biomedical and health research of excellence in Spain. Through these annual competitive grants, the ISCIII not only finances innovative and high-quality biomedical research projects, but also bets on strengthening the scientific fabric and developing […]
Researchers expand the potential of a virus for new cancer therapies and state-of-the-art vaccines
Researchers from IDIBELL and UB has identified two regions within the Vaccinia virus genome, where there would be enough space to introduce several genetic sequences in a stable way
Revolution in mental health: the transdiagnostic approach opens the door to new therapies applicable to more than one disorder at a time
A macro research confirms the genetic relationship between 14 different psychiatric disorders and groups them into five new families.
A patch inspired by mussels could help reduce relapse of the most aggressive brain tumor
A study with the participation of Bellvitge Campus proposes a new strategy to act directly in the place where the tumor has been extracted: a patch that sticks to the brain tissue and traps the residual tumor cells
Bellvitge promotes an innovative approach to minority epilepsy through advanced genetic diagnosis
A study by Bellvitge Hospital and IDIBELL describes a new genetic variant of a type of minority epilepsy
